|
24.08.25 - 06:06
|
Israeli pioneer in lab-grown kidneys seeks China biotech funding (SCMP)
|
|
An Israeli hospital that has achieved a breakthrough in cultivating kidneys in laboratories is seeking funding, including from China, to advance into clinical trials, according to the project's lead researcher.
Sheba Medical Centre, in collaboration with Tel Aviv University, said it had successfully grown a synthetic 3D organ culture, or organoid, that was the first to survive beyond 34 weeks, marking a significant milestone in regenerative medicine. Previous attempts had not exceeded four......
|
|
|
23.08.25 - 18:09
|
HIMS Deadline: HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit (PR Newswire)
|
|
NEW YORK, Aug. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the "Class Period"), of the important August 25, 2025......
|
|
|
23.08.25 - 14:30
|
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit (PR Newswire)
|
|
NEW YORK, Aug. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"), of the important September......
|
|
|
|
|
|
|
|
23.08.25 - 07:06
|
Kobayashi Pharmaceutical Expands U.S. Factory (Nippon)
|
|
Osaka, Aug. 23 (Jiji Press)--Kobayashi Pharmaceutical Co. said Friday that it has expanded its factory in Georgia to double the production capacity of disposable hand warmers to meet growing demand in the United States. The 8-billion-yen expansion was completed on Aug. 12, the Japanese company said. The expanded facility is expected to go into operation by the end of fiscal 2025. The product......
|
|
|
|
|
|
|
|
|
|